Bulevirtide – March 2026

Powder for injection 2 mg

  • Brand names:
    • Hepcludex®
  • Pharmaceutical Company:
    • GILEAD SCIENCES PTY LTD
  • Condition/Indication: Chronic hepatitis D
  • Meeting Date: March 2026
Public Summary Documents
Related Public Summary Documents
Last updated
11 March 2026